E ‐Stilbene‐Based Hydrazide‐1,3,4‐Oxadiazole Hybrids as Potential Anticancer Dual Carbonic Anhydrase‐I and Thymidine Phosphorylase Inhibitors: In Vitro and In Silico Studies